Cargando…
Accounting for the increase in NSAID expenditure: substitution or leakage?
BACKGROUND: National Institute of Health and Clinical Excellence (NICE) guidance stated that a new form of non-steroidal anti-inflammatory drug (NSAID) (selective COX-2 inhibitors) should only be an option for arthritis patients at high risk of a gastro-intestinal (GI) event. Total expenditure on NS...
| Autores principales: | , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2006
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1501056/ https://www.ncbi.nlm.nih.gov/pubmed/16737538 http://dx.doi.org/10.1186/1478-7547-4-9 |